# Home

## **Elevate efficacy**, **ensure safety** and **improve patient quality of life** in your drug trials

![](https://clario.com/wp-content/uploads/2023/05/Quality-Icon-Reverse-RGB.svg)

### Efficacy

With **over 5,000** imaging studies, Clario brings proven response criteria expertise complemented by unmatched experience$1

![](https://clario.com/wp-content/uploads/2023/05/Safety-Icon-Reverse-RGB.svg)

### Safety

Clario’s commitment to patient safety is at the core of our drug development support$1

![](https://clario.com/wp-content/uploads/2023/05/Patient-Support-Icon-Reverse-RGB.svg)

### Quality of life

Clario prioritizes the impact of treatments on patients’ mental health and daily functionality, ensuring their well$1being remains paramount$1

[Find your endpoint solutions today](https://clario.com/solutions/)

![Endpoint Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/02/Endpoint-Icon-Reverse-RGB.svg)

## Clinical trial endpoint solutions

Watch this video to learn more about our collaborative approach to partnerships in clinical trials$1

**ABOUT CLARIO**

## Transforming lives with the most comprehensive endpoint technologies and solutions for clinical trial management$1

[About us](https://clario.com/about/)

### Scientific expertise

Our team of hundreds of clinical trial management experts ensures that therapeutic area and endpoint science informs all aspects of our evidence generation technologies$1 Combined with our extensive global regulatory experience, we provide certainty in the reliability and precision of clinical evidence across our technology portfolio, enabling site$1based, hybrid and decentralized clinical trials$1

### Global scale

Thousands of customer operations professionals deliver unrivaled global deployment capability$1 With trials in over 100 countries, translations in over 100 languages and experience built from the delivery of over 30,000 trials, we have the regulatory and operational expertise to execute globally$1

### Broadest endpoint services and technology platform

Our uniquely engineered and validated clinical trial management software, connected devices and [Artificial Intelligence (AI)](https://clario.com/solutions/ai/) solutions across [Cardiac Safety](https://clario.com/solutions/cardiac-solutions/), [eCOA](https://clario.com/solutions/ecoa/), [Medical Imaging](https://clario.com/solutions/medical-imaging/), [Precision Motion](https://clario.com/solutions/precision-motion/) and [Respiratory](https://clario.com/solutions/respiratory/) provide the broadest evidence generation platform in the industry$1

### Delivering decentralized trials with reliability and precision

Only Clario has the science, innovative technologies, regulatory expertise, and global operational infrastructure to power decentralized, hybrid and site$1based clinical trials – with reliability and precision$1 Clario offers sites and sponsors more clinical trial options, empowers patient choice, and provides the means to create diversity within clinical trials, improving health equity$1

![Woman using digital tablet while sitting on wheelchair](https://clario.com/wp-content/uploads/2021/10/woman-in-wheelchair-using-tablet.png)

#### **CLARIO SOLUTIONS**

## Our solutions simplify the trial process

At Clario we are simplifying the clinical trial process for sponsors, sites, and CROs$1 Our platform integrates the broadest endpoint technologies, fused with deep scientific expertise and global scale$1 With 24/7 partner and patient support, along with training and instructions integrated into our devices, our technology and clinical trial management and solutions drive successful adoption, compliance, and retention$1

[See our solutions](https://clario.com/solutions/)

## Why Clario?

![Thought Leadership Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/05/Thought-Leadership-Icon-Reverse-RGB.svg)

50$1

years of experience

![Consent Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/05/Consent-Icon-Reverse-RGB.svg)

30,000$1

clinical trial opportunities

![Regulatory Approval Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/05/Regulatory-Approval-Icon-Reverse-RGB.svg)

700$1

FDA and EMA new drug approvals

![Site Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/05/Site-Icon-Reverse-RGB.svg)

100$1

countries

![Drug Approval Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/05/Drug-Approval-Icon-Reverse-RGB.svg)

70%

of FDA and EMA new drug approvals since 2015

![Patient Support Icon Reverse RGB](https://clario.com/wp-content/uploads/2023/05/Patient-Support-Icon-Reverse-RGB.svg)

24/7

customer and patient support

## Inspired by impact, driven by purpose

We are always looking for the best talent to help us transform the lives of patients$1

 [Careers at Clario](https://clario.com/careers/)

 ![Business Woman Using Tablet](https://clario.com/wp-content/uploads/2021/10/Business-Woman-Using-Tablet.png)

## Let’s partner together

If you are looking to generate the richest evidence for your clinical trial, contact us$1

[Get started](#popup-1)

## Customer support

If you are an existing customer and you need support, we’re here to help$1

[Contact support](https://clario.com/contact/customer-support/)

## Latest news

What’s happening at Clario? Discover how Clario is driving innovation in clinical trial endpoint technology$1

[See all news](https://clario.com/about/newsroom/)

[### Biological Psychiatry Study Shows Speech$1Latency Vocal Biomarker Can Strengthen Drug–Placebo Separation in Schizophrenia Trials 

February 26, 2026Read more](https://clario.com/about/newsroom/biological-psychiatry-study-shows-speech-latency-vocal-biomarker-can-strengthen-drug-placebo-separation-in-schizophrenia-trials/)[### Clario leads the way in responsible artificial intelligence with ISO 42001 certification, audited by Schellman

February 18, 2026Read more](https://clario.com/about/newsroom/clario-leads-the-way-in-responsible-artificial-intelligence-with-iso-42001-certification-audited-by-schellman/)[### Thermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights

October 29, 2025Read more](https://clario.com/about/newsroom/thermo-fisher-scientific-to-acquire-clario-enabling-pharma-and-biotech-customers-to-accelerate-innovation-with-deeper-clinical-insights/)

We love meeting customers, sponsors and patients in person$1 Here’s where you can find us:

[See all upcoming events](https://clario.com/resources/events/)